6,8-Dihydroxy-4-(4-methoxyphenyl)-3,4-dihydrochromen-2-one

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 新黄酮类化合物
• 英文名称: 6,8-Dihydroxy-4-(4-methoxyphenyl)-3,4-dihydrochromen-2-one
• 英文别名: 6,8-dihydroxy-4-(4-methoxyphenyl)-3,4-dihydrochromen-2-one
• 化学式: C₁₆H₁₄O₅
• 分子量: 286.284
• InChiKey: WPDXGRAJEYQZGH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.55
• 重原子数：
  21.0
• 可旋转键数：
  2.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  75.99
• 氢给体数：
  2.0
• 氢受体数：
  5.0

反应信息

• 作为产物：
  描述：

  4-甲氧基苯甲醛 在 哌啶 、 吡啶 作用下， 生成 6,8-Dihydroxy-4-(4-methoxyphenyl)-3,4-dihydrochromen-2-one
  参考文献：
  名称：

  Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer’s disease agents

  摘要：

  Alzheimer's disease (AD) is a progressive neurological degenerative disease that has complex pathogenesis. A variety of studies in humans indicate that several enzymes inhibitors can be useful in the treatment of AD, including acetylcholinesterase (AchE), butyrylcholinesterase (BuChE) and monoamine oxidase (MAO). Various substituted 4-arylcoumarin derivatives were synthesised, and their activity in vitro were investigated, including AChE/BuChE inhibitory activity, MAO inhibitory activity, and antioxidant activity. Most of the compounds were found to exhibit high inhibitory activity, and individual compounds have extremely excellent activities. Therefore 4-arylcoumarins provides an idea for drugs design for the development of therapeutic or preventive agents for AD.

  DOI：

  10.1016/j.bmcl.2019.126900

文献信息

• Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer’s disease agents
  作者：Yinling Yun、Jie Yang、Yuhang Miao、Xiaojing Wang、Jie Sun

  DOI：10.1016/j.bmcl.2019.126900

  日期：2020.2

  Alzheimer's disease (AD) is a progressive neurological degenerative disease that has complex pathogenesis. A variety of studies in humans indicate that several enzymes inhibitors can be useful in the treatment of AD, including acetylcholinesterase (AchE), butyrylcholinesterase (BuChE) and monoamine oxidase (MAO). Various substituted 4-arylcoumarin derivatives were synthesised, and their activity in vitro were investigated, including AChE/BuChE inhibitory activity, MAO inhibitory activity, and antioxidant activity. Most of the compounds were found to exhibit high inhibitory activity, and individual compounds have extremely excellent activities. Therefore 4-arylcoumarins provides an idea for drugs design for the development of therapeutic or preventive agents for AD.